A detailed history of State Of Wisconsin Investment Board transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 76,931 shares of DNLI stock, worth $2.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76,931
Previous 80,393 4.31%
Holding current value
$2.07 Million
Previous $1.65 Million 8.31%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$14.96 - $23.22 $51,791 - $80,387
-3,462 Reduced 4.31%
76,931 $1.79 Million
Q1 2024

May 14, 2024

SELL
$15.83 - $23.35 $176,156 - $259,838
-11,128 Reduced 12.16%
80,393 $1.65 Million
Q4 2023

Feb 12, 2024

SELL
$16.2 - $23.18 $102,627 - $146,845
-6,335 Reduced 6.47%
91,521 $1.96 Million
Q3 2023

Nov 14, 2023

SELL
$20.63 - $30.17 $15,121 - $22,114
-733 Reduced 0.74%
97,856 $2.02 Million
Q2 2023

Aug 14, 2023

BUY
$23.37 - $32.96 $251,531 - $354,748
10,763 Added 12.25%
98,589 $2.91 Million
Q1 2023

May 15, 2023

BUY
$21.91 - $32.67 $27,606 - $41,164
1,260 Added 1.46%
87,826 $2.02 Million
Q4 2022

Feb 14, 2023

SELL
$26.28 - $33.92 $26,017 - $33,580
-990 Reduced 1.13%
86,566 $2.41 Million
Q3 2022

Nov 14, 2022

BUY
$25.97 - $38.53 $10,829 - $16,067
417 Added 0.48%
87,556 $2.69 Million
Q2 2022

Aug 15, 2022

SELL
$20.88 - $35.19 $723,721 - $1.22 Million
-34,661 Reduced 28.46%
87,139 $2.57 Million
Q4 2021

Feb 11, 2022

SELL
$42.59 - $55.02 $93,698 - $121,044
-2,200 Reduced 1.77%
121,800 $5.43 Million
Q3 2021

Nov 12, 2021

BUY
$48.48 - $78.23 $63,023 - $101,699
1,300 Added 1.06%
124,000 $6.26 Million
Q2 2021

Aug 12, 2021

BUY
$50.3 - $78.44 $1.66 Million - $2.59 Million
33,000 Added 36.79%
122,700 $9.63 Million
Q1 2021

May 17, 2021

SELL
$53.8 - $81.53 $193,680 - $293,508
-3,600 Reduced 3.86%
89,700 $5.12 Million
Q4 2020

Feb 03, 2021

SELL
$36.89 - $93.56 $280,364 - $711,056
-7,600 Reduced 7.53%
93,300 $7.82 Million
Q3 2020

Nov 16, 2020

BUY
$23.13 - $38.84 $416,340 - $699,120
18,000 Added 21.71%
100,900 $3.62 Million
Q2 2020

Aug 12, 2020

BUY
$16.01 - $28.82 $36,823 - $66,286
2,300 Added 2.85%
82,900 $2.01 Million
Q1 2020

May 06, 2020

BUY
$14.2 - $27.98 $123,540 - $243,426
8,700 Added 12.1%
80,600 $1.41 Million
Q3 2019

Nov 12, 2019

BUY
$15.32 - $21.92 $87,324 - $124,944
5,700 Added 8.61%
71,900 $1.1 Million
Q2 2019

Aug 14, 2019

BUY
$18.5 - $28.14 $83,250 - $126,630
4,500 Added 7.29%
66,200 $1.37 Million
Q1 2019

May 13, 2019

BUY
$17.99 - $24.65 $253,658 - $347,565
14,100 Added 29.62%
61,700 $1.43 Million
Q4 2018

Feb 11, 2019

BUY
$13.88 - $21.75 $8,328 - $13,050
600 Added 1.28%
47,600 $983,000
Q3 2018

Nov 14, 2018

BUY
$12.46 - $21.74 $585,620 - $1.02 Million
47,000 New
47,000 $1.02 Million

Others Institutions Holding DNLI

About Denali Therapeutics Inc.


  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.6B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.